跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 660 条关于
“Navidea Biopharmaceuticals”
全部
660
临床试验
12
药物
188
机构
100
资讯
360
去年
FDA Approves Lymphoseek for Head and Neck Cancer Lymphatic Mapping
去年
Provectus Biopharmaceuticals Launches VisiRose for Ophthalmic Therapies
去年
Angitia Biopharmaceuticals Doses First Patient in Phase 2 Trial of AGA2118 for Osteoporosis
9个月前
SK Biopharmaceuticals' Cenobamate and Solriamfetol Receive NMPA Approval for China Market
9个月前
SK Biopharmaceuticals Licenses WT-7695 Radiopharmaceutical Targeting CA9 for Solid Tumors
去年
Paradigm Biopharmaceuticals Advances Phase 3 Trial for Osteoarthritis Treatment
11个月前
SK Biopharmaceuticals and Eurofarma Launch AI-Powered Epilepsy Management Joint Venture
5个月前
SK Biopharmaceuticals Launches Cenobamate in China, Marking Major Milestone for Epilepsy Treatment
9年前
Alder BioPharmaceuticals Announces Positive Eptinezumab Phase 3 Results for Migraine Prevention
去年
Korean Hospitals Secure Approval for SK Biopharmaceuticals' Cenobamate for Epilepsy Treatment
第 1 页,共 36 页
上一页
下一页